Luye Pharma grants $AZN exclusive rights to promote Xuezhikang Capsules in mainland China httpswww.prnewswire.comnewsreleasesluyepharmareachesstrategicpartnershipwithastrazenecastrengthenscommitmenttocardiovasculartherapeuticfield300779
Luye Pharma grants $AZN exclusive rights to promote Xuezhikang Capsules in mainland China https://www.prnewswire.com/news-releases/luye-pharma-reaches-strategic-partnership-with-astrazeneca-strengthens-commitment-to-cardiovascular-therapeutic-field-300779
More From BioPortfolio on "Luye Pharma grants $AZN exclusive rights to promote Xuezhikang Capsules in mainland China https://www.prnewswire.com/news-releases/luye-pharma-reaches-strategic-partnership-with-astrazeneca-strengthens-commitment-to-cardiovascular-therapeutic-field-300779"